| Direct Competitor Comparison | |
|---|
| TEVA | ACT | PVT1 | PVT2 | Industry |
|---|
| Market Cap: | 32.39B | 13.61B | N/A | N/A | 465.64M |
|---|
| Employees: | 45,948 | 17,700 | 14,0421 | N/A | 538.00 |
|---|
| Qtrly Rev Growth (yoy): | -0.08 | 0.13 | N/A | N/A | 0.32 |
|---|
| Revenue (ttm):
| 20.32B | 5.91B | 1.86B1 | N/A | 587.73M |
|---|
| Gross Margin (ttm): | 0.53 | 0.45 | N/A | N/A | 0.83 |
|---|
| EBITDA (ttm): | 6.02B | 1.29B | N/A | N/A | 36.36M |
|---|
| Operating Margin (ttm):
| 0.21 | 0.12 | N/A | N/A | 0.08 |
|---|
| Net Income (ttm): | 1.96B | 97.30M | -528.80M1 | N/A | N/A |
|---|
| EPS (ttm): | 2.25 | 0.76 | N/A | N/A | 0.18 |
|---|
| P/E (ttm): | 16.80 | 140.12 | N/A | N/A | 53.73 |
|---|
| PEG (5 yr expected): | 1.24 | 0.87 | N/A | N/A | 0.30 |
|---|
| P/S (ttm): | 1.61 | 2.26 | N/A | N/A | 2.97 |
|---|
|
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.59 | 0.01 | 79.19B | 17.87 |
|---|
| Genentech, Inc. | Private - View Profile |
|---|
| Biogen Idec Inc. | BIIB | 217.30 | 0.01 | 51.58B | 34.48 |
|---|
| Genzyme Corporation | Private - View Profile |
|---|
| Merck Serono S.A. | Private - View Profile |
|---|
| Gilead Sciences Inc. | GILD | 52.18 | 0.04 | 79.44B | 31.82 |
|---|
| MedImmune, L.L.C. | Private - View Profile |
|---|
| Life Technologies Corporation | LIFE | 73.63 | 0.00 | 12.55B | 30.65 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 37.80 | -0.01 | 32.39B | 16.80 |
|---|
| Sandoz International GmbH | Private - View Profile |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 106.49 | 0.02 | 13.61B | 140.12 |
|---|
| Ranbaxy Laboratories Limited | Private - View Profile |
|---|
| Mylan, Inc. | MYL | 28.83 | 0.00 | 11.40B | 18.97 |
|---|
| Pfizer Inc. | PFE | 29.27 | 0.01 | 210.42B | 15.08 |
|---|
| Johnson & Johnson | JNJ | 85.16 | 0.01 | 238.05B | 23.13 |
|---|
| GlaxoSmithKline plc | GSK | 51.43 | -0.00 | 124.56B | 18.80 |
|---|
| Sanofi | SNY | 55.00 | 0.04 | 145.57B | 22.72 |
|---|
| Novartis AG | NVS | 73.50 | -0.00 | 180.61B | 18.65 |
|---|
| Roche Holding AG | RHHBY | 62.30 | 0.01 | 211.44B | 20.85 |
|---|
| AstraZeneca PLC | AZN | 51.43 | -0.00 | 64.29B | 11.38 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.06 | 0.00 | 58.21B | 11.30 |
|---|
| Bristol-Myers Squibb Company | BMY | 40.01 | 0.01 | 65.51B | 45.31 |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|